Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Cash from Investing Activities (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Cash from Investing Activities for 2 consecutive years, with $15.2 million as the latest value for Q4 2023.

  • On a quarterly basis, Cash from Investing Activities rose 12.19% to $15.2 million in Q4 2023 year-over-year; TTM through Dec 2023 was -$29.6 million, a 87.75% increase, with the full-year FY2024 number at -$154.5 million, down 421.52% from a year prior.
  • Cash from Investing Activities was $15.2 million for Q4 2023 at LENZ Therapeutics, up from -$17.9 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $15.2 million in Q4 2023 to a low of -$170.7 million in Q1 2022.